Font Size: a A A
Keyword [T315I]
Result: 1 - 18 | Page: 1 of 1
1. Matrine Induces Apoptosis Of Chronic Myelogenous Leukemia Cells Viaβ-catenin/c-Myc Signaling Pathway
2. The Effects Of HIF-1α& Downstream VEGF On The Proliferation Of CML Cells And The Synergistic Therapeutic Strategies Of T315I Mutant CML
3. The Role Of Interference Apg-2Gene In BaF3-IGR1, BaF3-p210and BaF3-p210-the T315I Cells
4. Study Of Clinical Treatment Of Chronic Myeloid Leukemia
5. The Degradation Of BCR/ABL By Chimeric Ubiquitin Ligase And Its Growth-inhibitory Effect On Chronic Myelogenous Leukaemia Cells
6. Identification Of T315I Point Mutation Of Bcr/abl Fusion Gene By Mutant Enriched AS-PCR Assay Method And Clinical Application
7. Theoretical Studies Of 3D-QSAR, Docking And Molecular Dynamics Simulations Studies On Abl Kinase Inhibitors
8. Effects And Mechanisms Of Hydroxychloroauine On Tvrosine Kinase Inhibitors-Resistant Chronic Mveloid Leukemia Cell
9. The Effects Of Inhibiting BCR/ABL Protein Through ATP-competitive Independent Pathway In CML
10. Beclin-1 Overexpression Induced Autophagy On Inhibitory Effect Of Bcr-Abl And Its Molecular Mechanism
11. Analysis Of Clinical Characteristics And Efficacy Of Patients With Chronic Myeloid Leukemia Complicated With T315I Mutation
12. Expression And Significance Of EBF-1 Gene In Acute Leukemia Ponatinib As Salvage Therapy In Relapse Chronic Myeloid Leukemia With T315I Mutation After Allogeneic Stem Cell Transplantation
13. Study On The Membrane Tablet Of A New Generation Of Tyrosine Kinase(BCR-ABL)T315I Inhibitor Procyclotinib CY03529B
14. Value Of CAR-T Cell Therapy For Ph+ Acute B-cell Lymphoblastic Leukemia With T315I Mutation
15. Design,Synthesis And Biological Evaluation Of Small Molecule Degradation Agent Targeting Bcr-AblT315I Based On PROTAC Principle
16. Study On Effect Of Chidamide On T315I Mutant CML Cells And Exploration Of Effect Of HMGB1 On CML Cells
17. Study On Apoptosis Mechanism Induced By Cochinchina Momordica Seed Extract In Chronic Myeloid Leukemia Cells
18. Combing Optimization Screening And Activity Evaluation To Discover A Novel BCR-ABL/T315I Tyrosine Kinase Inhibitor
  <<First  <Prev  Next>  Last>>  Jump to